Search

everythinglearnresearchcommunity

for

Search:↓

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

New methods to test hair growth treatments have been developed.

Ganoderma lucidum extract may help treat stress-related hair loss.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Melatonin may protect inner ear cells from damage by reducing cell death and oxidative stress, potentially treating sudden hearing loss.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Combining narrow-band ultraviolet B light and stem cell transplantation helps repigmentation in vitiligo by maintaining calcium balance in mice.

The text talks about a rare skin condition causing hair loss and suggests that people with this should also check their lung and heart health.

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

Circadian clock genes are important for hair growth and may affect aging-related hair loss and graying.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Child abuse is linked to higher BMI, but not because of hair cortisol or cortisone levels.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Estradiol may protect ear cells from hearing loss caused by a chemotherapy drug by activating a protective pathway.

Massaging the scalp with a cosmetic containing certain natural inhibitors can significantly regrow hair in men with pattern baldness.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

SkQ1 antioxidant improved health and lifespan in mice.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.